176 related articles for article (PubMed ID: 7551818)
1. Investigation of beta-oxidation intermediates in normal and MCAD-deficient human fibroblasts using tandem mass spectrometry.
Nada MA; Chace DH; Sprecher H; Roe CR
Biochem Mol Med; 1995 Feb; 54(1):59-66. PubMed ID: 7551818
[TBL] [Abstract][Full Text] [Related]
2. A method for quantitative acylcarnitine profiling in human skin fibroblasts using unlabelled palmitic acid: diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of MCAD deficiency.
Okun JG; Kölker S; Schulze A; Kohlmüller D; Olgemöller K; Lindner M; Hoffmann GF; Wanders RJ; Mayatepek E
Biochim Biophys Acta; 2002 Oct; 1584(2-3):91-8. PubMed ID: 12385891
[TBL] [Abstract][Full Text] [Related]
3. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood.
Van Hove JL; Zhang W; Kahler SG; Roe CR; Chen YT; Terada N; Chace DH; Iafolla AK; Ding JH; Millington DS
Am J Hum Genet; 1993 May; 52(5):958-66. PubMed ID: 8488845
[TBL] [Abstract][Full Text] [Related]
4. Analysis of mitochondrial fatty acid oxidation intermediates by tandem mass spectrometry from intact mitochondria prepared from homogenates of cultured fibroblasts, skeletal muscle cells, and fresh muscle.
Tyni T; Pourfarzam M; Turnbull DM
Pediatr Res; 2002 Jul; 52(1):64-70. PubMed ID: 12084849
[TBL] [Abstract][Full Text] [Related]
5. Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency.
Andresen BS; Dobrowolski SF; O'Reilly L; Muenzer J; McCandless SE; Frazier DM; Udvari S; Bross P; Knudsen I; Banas R; Chace DH; Engel P; Naylor EW; Gregersen N
Am J Hum Genet; 2001 Jun; 68(6):1408-18. PubMed ID: 11349232
[TBL] [Abstract][Full Text] [Related]
6. Evidence for intermediate channeling in mitochondrial beta-oxidation.
Nada MA; Rhead WJ; Sprecher H; Schulz H; Roe CR
J Biol Chem; 1995 Jan; 270(2):530-5. PubMed ID: 7822275
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of acyl-CoA and acylcarnitine esters accumulated during abnormal mitochondrial fatty acid oxidation.
Kler RS; Jackson S; Bartlett K; Bindoff LA; Eaton S; Pourfarzam M; Frerman FE; Goodman SI; Watmough NJ; Turnbull DM
J Biol Chem; 1991 Dec; 266(34):22932-8. PubMed ID: 1744086
[TBL] [Abstract][Full Text] [Related]
8. Prenatal diagnosis of mitochondrial fatty acid oxidation defects.
Nada MA; Vianey-Saban C; Roe CR; Ding JH; Mathieu M; Wappner RS; Bialer MG; McGlynn JA; Mandon G
Prenat Diagn; 1996 Feb; 16(2):117-24. PubMed ID: 8650121
[TBL] [Abstract][Full Text] [Related]
9. Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry.
Clayton PT; Doig M; Ghafari S; Meaney C; Taylor C; Leonard JV; Morris M; Johnson AW
Arch Dis Child; 1998 Aug; 79(2):109-15. PubMed ID: 9797589
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactive enzyme protein in medium-chain acyl-CoA dehydrogenase deficiency.
Ogilvie I; Jackson S; Bartlett K; Turnbull DM
Biochem Med Metab Biol; 1991 Dec; 46(3):373-9. PubMed ID: 1793614
[TBL] [Abstract][Full Text] [Related]
11. Long-chain acyl-CoA profiles in cultured fibroblasts from patients with defects in fatty acid oxidation.
Tamvakopoulos CS; Willi S; Anderson VE; Hale DE
Biochem Mol Med; 1995 Jun; 55(1):15-21. PubMed ID: 7551821
[TBL] [Abstract][Full Text] [Related]
12. Urinary medium-chain acylcarnitines in medium-chain acyl-CoA dehydrogenase deficiency, medium-chain triglyceride feeding and valproic acid therapy: sensitivity and specificity of the radioisotopic exchange/high performance liquid chromatography method.
Schmidt-Sommerfeld E; Penn D; Rinaldo P; Kossak D; Li BU; Huang ZH; Gage DA
Pediatr Res; 1992 Jun; 31(6):545-51. PubMed ID: 1635814
[TBL] [Abstract][Full Text] [Related]
13. Analysis of fatty acid oxidation intermediates in cultured fibroblasts to detect mitochondrial oxidation disorders.
Pourfarzam M; Schaefer J; Turnbull DM; Bartlett K
Clin Chem; 1994 Dec; 40(12):2267-75. PubMed ID: 7988014
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies.
Carpenter K; Wiley V; Sim KG; Heath D; Wilcken B
Arch Dis Child Fetal Neonatal Ed; 2001 Sep; 85(2):F105-9. PubMed ID: 11517203
[TBL] [Abstract][Full Text] [Related]
15. Determination of medium chain acyl-CoA dehydrogenase activity in cultured skin fibroblasts using mass spectrometry.
Niezen-Koning KE; Chapman TE; Mulder IE; Smit GP; Reijngoud DJ; Berger R
Clin Chim Acta; 1991 Jun; 199(2):173-84. PubMed ID: 1873916
[TBL] [Abstract][Full Text] [Related]
16. A novel functional assay for simultaneous determination of total fatty acid beta-oxidation flux and acylcarnitine profiling in human skin fibroblasts using (2)H(31)-palmitate by isotope ratio mass spectrometry and electrospray tandem mass spectrometry.
Law LK; Tang NL; Hui J; Ho CS; Ruiter J; Fok TF; Wanders RJ; Lam CW
Clin Chim Acta; 2007 Jul; 382(1-2):25-30. PubMed ID: 17442290
[TBL] [Abstract][Full Text] [Related]
17. In vitro correction of medium chain acyl CoA dehydrogenase deficiency with a recombinant adenoviral vector.
Schowalter DB; Matern D; Vockley J
Mol Genet Metab; 2005 Jun; 85(2):88-95. PubMed ID: 15896652
[TBL] [Abstract][Full Text] [Related]
18. Biosynthesis of variant medium chain acyl-CoA dehydrogenase in cultured fibroblasts from patients with medium chain acyl-CoA dehydrogenase deficiency.
Ikeda Y; Hale DE; Keese SM; Coates PM; Tanaka K
Pediatr Res; 1986 Sep; 20(9):843-7. PubMed ID: 3748657
[TBL] [Abstract][Full Text] [Related]
19. Heat stress deteriorates mitochondrial beta-oxidation of long-chain fatty acids in cultured fibroblasts with fatty acid beta-oxidation disorders.
Li H; Fukuda S; Hasegawa Y; Purevsuren J; Kobayashi H; Mushimoto Y; Yamaguchi S
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1669-72. PubMed ID: 20207594
[TBL] [Abstract][Full Text] [Related]
20. Effect of heat stress and bezafibrate on mitochondrial beta-oxidation: comparison between cultured cells from normal and mitochondrial fatty acid oxidation disorder children using in vitro probe acylcarnitine profiling assay.
Li H; Fukuda S; Hasegawa Y; Kobayashi H; Purevsuren J; Mushimoto Y; Yamaguchi S
Brain Dev; 2010 May; 32(5):362-70. PubMed ID: 19589653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
